165 related articles for article (PubMed ID: 30100995)
21. Roles of aldo-keto reductases 1B10 and 1C3 and ATP-binding cassette transporter in docetaxel tolerance.
Matsunaga T; Saito H; Endo S; Iguchi K; Soda M; El-Kabbani O; Hara A; Ikari A
Free Radic Res; 2016 Dec; 50(12):1296-1308. PubMed ID: 27629782
[TBL] [Abstract][Full Text] [Related]
22. LGR5 Is a Gastric Cancer Stem Cell Marker Associated with Stemness and the EMT Signature Genes NANOG, NANOGP8, PRRX1, TWIST1, and BMI1.
Wang B; Chen Q; Cao Y; Ma X; Yin C; Jia Y; Zang A; Fan W
PLoS One; 2016; 11(12):e0168904. PubMed ID: 28033430
[TBL] [Abstract][Full Text] [Related]
23. MicroRNA-181a promotes docetaxel resistance in prostate cancer cells.
Armstrong CM; Liu C; Lou W; Lombard AP; Evans CP; Gao AC
Prostate; 2017 Jun; 77(9):1020-1028. PubMed ID: 28485104
[TBL] [Abstract][Full Text] [Related]
24. Exploitation of the Androgen Receptor to Overcome Taxane Resistance in Advanced Prostate Cancer.
Martin SK; Kyprianou N
Adv Cancer Res; 2015; 127():123-58. PubMed ID: 26093899
[TBL] [Abstract][Full Text] [Related]
25. Overcoming ABCB1 mediated multidrug resistance in castration resistant prostate cancer.
Ishov A; Sarwar S; Morozov V; Newcomb M; Guryanova O
Res Sq; 2024 Apr; ():. PubMed ID: 38746435
[TBL] [Abstract][Full Text] [Related]
26. Inhibition of ZEB1 reverses EMT and chemoresistance in docetaxel-resistant human lung adenocarcinoma cell line.
Ren J; Chen Y; Song H; Chen L; Wang R
J Cell Biochem; 2013 Jun; 114(6):1395-403. PubMed ID: 23255418
[TBL] [Abstract][Full Text] [Related]
27. NANOGP8 is the key regulator of stemness, EMT, Wnt pathway, chemoresistance, and other malignant phenotypes in gastric cancer cells.
Ma X; Wang B; Wang X; Luo Y; Fan W
PLoS One; 2018; 13(4):e0192436. PubMed ID: 29689047
[TBL] [Abstract][Full Text] [Related]
28. Eggmanone Effectively Overcomes Prostate Cancer Cell Chemoresistance.
Xie C; Lin PJ; Hao J
Biomedicines; 2021 May; 9(5):. PubMed ID: 34066000
[TBL] [Abstract][Full Text] [Related]
29. High-throughput mRNA and miRNA profiling of epithelial-mesenchymal transition in MDCK cells.
Shukla P; Vogl C; Wallner B; Rigler D; Müller M; Macho-Maschler S
BMC Genomics; 2015 Nov; 16():944. PubMed ID: 26572553
[TBL] [Abstract][Full Text] [Related]
30. Transcriptional Profiling of Tumorspheres Reveals TRPM4 as a Novel Stemness Regulator in Breast Cancer.
Verigos J; Kordias D; Papadaki S; Magklara A
Biomedicines; 2021 Oct; 9(10):. PubMed ID: 34680485
[TBL] [Abstract][Full Text] [Related]
31. Establishment and characterization of a docetaxel-resistant human prostate cancer cell line.
Liu J; Huang Y; Zhu D; Dai Y; Liu D; Zhai Y; Liang X; Wu L; Zhao Q
Oncol Lett; 2020 Nov; 20(5):230. PubMed ID: 32968452
[TBL] [Abstract][Full Text] [Related]
32. HMGB1 induction of clusterin creates a chemoresistant niche in human prostate tumor cells.
Zhou J; Chen X; Gilvary DL; Tejera MM; Eksioglu EA; Wei S; Djeu JY
Sci Rep; 2015 Oct; 5():15085. PubMed ID: 26469759
[TBL] [Abstract][Full Text] [Related]
33. Activity of docetaxel in paclitaxel-resistant ovarian cancer cells.
Sato S; Kigawa J; Kanamori Y; Itamochi H; Oishi T; Shimada M; Iba T; Naniwa J; Uegaki K; Terakawa N
Cancer Chemother Pharmacol; 2004 Mar; 53(3):247-52. PubMed ID: 14610615
[TBL] [Abstract][Full Text] [Related]
34. Analysis of resistance-associated gene expression in docetaxel-resistant prostate cancer cells.
Lee S; Kim K; Ho JN; Jin H; Byun SS; Lee E
Oncol Lett; 2017 Sep; 14(3):3011-3018. PubMed ID: 28928839
[TBL] [Abstract][Full Text] [Related]
35. INPP4B reverses docetaxel resistance and epithelial-to-mesenchymal transition via the PI3K/Akt signaling pathway in prostate cancer.
Chen H; Li H; Chen Q
Biochem Biophys Res Commun; 2016 Aug; 477(3):467-72. PubMed ID: 27318090
[TBL] [Abstract][Full Text] [Related]
36. Metastatic neuroblastoma cancer stem cells exhibit flexible plasticity and adaptive stemness signaling.
Pandian V; Ramraj S; Khan FH; Azim T; Aravindan N
Stem Cell Res Ther; 2015 Feb; 6(1):2. PubMed ID: 25888913
[TBL] [Abstract][Full Text] [Related]
37. Anticancer Effect by Combined Treatment of
Jung EJ; Kim HJ; Shin SC; Kim GS; Jung JM; Hong SC; Chung KH; Kim CW; Lee WS
Curr Issues Mol Biol; 2024 Feb; 46(2):1621-1634. PubMed ID: 38392223
[TBL] [Abstract][Full Text] [Related]
38. Molecular mechanisms of docetaxel resistance in prostate cancer.
Sekino Y; Teishima J
Cancer Drug Resist; 2020; 3(4):676-685. PubMed ID: 35582222
[TBL] [Abstract][Full Text] [Related]
39. Mechanisms of resistance to systemic therapy in metastatic castration-resistant prostate cancer.
Galletti G; Leach BI; Lam L; Tagawa ST
Cancer Treat Rev; 2017 Jun; 57():16-27. PubMed ID: 28527407
[TBL] [Abstract][Full Text] [Related]
40. DKK4-knockdown enhances chemosensitivity of A549/DTX cells to docetaxel.
Yang X; Liu Y; Li W; Li A; Sun Q
Acta Biochim Biophys Sin (Shanghai); 2017 Oct; 49(10):899-906. PubMed ID: 28981599
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
